Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Becton Dickinson
NYSE:BDX Community
1
Narratives
written by author
0
Comments
on narratives written by author
27
Fair Values set
on narratives written by author
Create a narrative
Becton Dickinson
Popular
Undervalued
Overvalued
Becton Dickinson
WA
Analyst Price Target
Consensus Narrative from 15 Analysts
Advancements In Patient Monitoring And Drug Delivery Will Strengthen Future Market Position
Key Takeaways Strategic focus on drug delivery, robotics, and patient monitoring positions BD for growth in expanding markets and future earnings enhancement. Operational improvements and new product launches support sustained revenue growth and increased earnings per share through effective capital deployment.
View narrative
US$277.80
FV
18.1% undervalued
intrinsic discount
6.00%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
BDX
Becton Dickinson
Your Fair Value
US$
Current Price
US$227.43
7.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
27b
2015
2018
2021
2024
2025
2027
2030
Revenue US$26.6b
Earnings US$2.2b
Advanced
Set as Fair Value